While GLP-1 medications work through a single hormone pathway to suppress appetite, tirzepatide activates both GLP-1 and GIP receptors, leading to stronger appetite regulation, improved insulin sensitivity, and greater metabolic impact for some patients
This compound is part of our Peptide Blends research category, which includes multi-component peptide formulations studied in controlled laboratory environments
Why Clients Choose Peptides Enhanced recovery & tissue repair Improved collagen production & skin elasticity Metabolic & lean muscle support Libido & sexual wellness optimization Improved sleep, focus & immune resilience Reduced inflammation & joint discomfort Our Most Popular Peptide Therapies Each peptide we offer is medically formulated and backed by research
In the case of GLP-1 agonists, which stands for glucagon-like peptide-1, were introducing a substance that mimics you GLP-1 hormones, which are responsible for: Signaling your pancreas to produce insulin, the hormone that ferries glucose out of your bloodstream Slowing digestion Blocking the secretion of glucagon, which raises your blood sugar levels Signaling your brain that youre full or satisfied Due to their ability to regulate the level of blood sugar in your system, GLP-1 agonists were first introduced to combat diabetes
